Mesenchymal mode of migration participates in pulmonary metastasis of mouse osteosarcoma LM8

Clinical and Experimental Metastasis

Volumn 27, Issue 8, 2010, Pages 619-630

  Yui, Yoshihiro ^a,b   Itoh, Kazuyuki ^b   Yoshioka, Kiyoko ^b   Naka, Norifumi ^b   Watanabe, Motonobu ^a   Hiraumi, Yoshimi ^a   Matsubara, Hiroshi ^a   Watanabe, Ken Ichiro ^a   Sano, Kazumi ^c   Nakahata, Tatsutoshi ^a   Adachi, Souichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^c MEIJI PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cdc42; Irinotecan; Mesenchymal migration; Metastasis; Osteosarcoma

Indexed keywords

BETA1 INTEGRIN; FOCAL ADHESION KINASE; IRINOTECAN; PROTEIN CDC42;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL CULTURE; CELL MIGRATION; CELL STRUCTURE; FILOPODIUM; IMMUNOHISTOCHEMISTRY; LUNG METASTASIS; MESENCHYME; MOUSE; NONHUMAN; OSTEOSARCOMA;

ANIMALS; CAMPTOTHECIN; CDC42 GTP-BINDING PROTEIN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; DISEASE MODELS, ANIMAL; LUNG NEOPLASMS; MESODERM; MICE; MICE, INBRED C3H; OSTEOSARCOMA; SIGNAL TRANSDUCTION;

EID: 78649330831     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-010-9352-x     Document Type: Article

References (39)

1. IJ Lewis MA Nooij J Whelan, et al. 2007 Improvement in histologic response but not survival in osteosarcoma patients treated with intensified chemotherapy: a randomized phase III trial of the European Osteosarcoma Intergroup J Natl Cancer Inst 99 2 112 128 1:CAS:528:DC%2BD2sXhvVOhtbg%3D 10.1093/jnci/djk015 17227995
2. PA Meyers CL Schwartz M Krailo, et al. 2005 Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate J Clin Oncol 23 9 2004 2011 1:CAS:528:DC%2BD2MXjt1Cku7k%3D 10.1200/JCO.2005.06.031 15774791 (Pubitemid 46211380)
3. AM Goorin DJ Schwartzentruber M Devidas, et al. 2003 Presurgical chemotherapy compared with immediate surgery and adjuvant chemotherapy for nonmetastatic osteosarcoma: Pediatric Oncology Group Study POG-8651 J Clin Oncol 21 8 1574 1580 1:CAS:528:DC%2BD2cXptlCksLg%3D 10.1200/JCO.2003.08.165 12697883 (Pubitemid 46594112)
4. L Kager A Zoubek U Potschger, et al. 2003 Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols J Clin Oncol 21 10 2011 2018 10.1200/JCO.2003.08.132 12743156 (Pubitemid 46606391)
5. TB Dunn HB Andervont 1963 Histology of some neoplasms and non-neoplastic lesions found in wild mice maintained under laboratory conditions J Natl Cancer Inst 31 873 901 1:STN:280:DyaF2c7jtFGqsg%3D%3D 14173606
6. T Asai T Ueda K Itoh, et al. 1998 Establishment and characterization of a murine osteosarcoma cell line (LM8) with high metastatic potential to the lung Int J Cancer 76 3 418 422 1:CAS:528:DyaK1cXjtVOqs7c%3D 10.1002/(SICI)1097- 0215(19980504)76:3<418::AID-IJC21>3.0.CO;2-5 9579581 (Pubitemid 28282943)
7. E Sahai 2007 Illuminating the metastatic process Nat Rev Cancer 7 10 737 749 1:CAS:528:DC%2BD2sXhtVOnsr3N 10.1038/nrc2229 17891189 (Pubitemid 47463672)
8. GP Gupta J Massague 2006 Cancer metastasis: building a framework Cell 127 4 679 695 1:CAS:528:DC%2BD28Xht1yqs7rL 10.1016/j.cell.2006.11.001 17110329 (Pubitemid 44781029)
9. K Pantel RH Brakenhoff 2004 Dissecting the metastatic cascade Nat Rev Cancer 4 6 448 456 1:CAS:528:DC%2BD2cXksVaisbY%3D 10.1038/nrc1370 15170447
10. H Yamaguchi J Wyckoff J Condeelis 2005 Cell migration in tumors Curr Opin Cell Biol 17 5 559 564 1:CAS:528:DC%2BD2MXhtVWnsb7E 10.1016/j.ceb.2005.08.002 16098726 (Pubitemid 41267171)
11. P Friedl K Wolf 2003 Tumour-cell invasion and migration: diversity and escape mechanisms Nat Rev Cancer 3 5 362 374 1:CAS:528:DC%2BD3sXjtlals7o%3D 10.1038/nrc1075 12724734 (Pubitemid 37328856)
12. P Friedl 2004 Prespecification and plasticity: shifting mechanisms of cell migration Curr Opin Cell Biol 16 1 14 23 1:CAS:528:DC%2BD2cXitlSmsrY%3D 10.1016/j.ceb.2003.11.001 15037300 (Pubitemid 38368147)
13. JP Thiery 2002 Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2 6 442 454 1:CAS:528:DC%2BD38Xksl2ltr8%3D 10.1038/nrc822 12189386
14. G Poste IJ Fidler 1980 The pathogenesis of cancer metastasis Nature 283 5743 139 146 1:STN:280:DyaL3c%2FnvVWqtw%3D%3D 10.1038/283139a0 6985715 (Pubitemid 10171124)
15. XD Ren WB Kiosses MA Schwartz 1999 Regulation of the small GTP-binding protein Rho by cell adhesion and the cytoskeleton EMBO J 18 3 578 585 1:CAS:528:DyaK1MXhslaisrY%3D 10.1093/emboj/18.3.578 9927417 (Pubitemid 29057242)
16. A Mettouchi S Klein W Guo, et al. 2001 Integrin-specific activation of Rac controls progression through the G(1) phase of the cell cycle Mol Cell 8 1 115 127 1:CAS:528:DC%2BD3MXls1Wnu7s%3D 10.1016/S1097-2765(01)00285-4 11511365 (Pubitemid 32772910)
17. K Yoshioka S Nakamori K Itoh 1999 Overexpression of small GTP-binding protein RhoA promotes invasion of tumor cells Cancer Res 59 8 2004 2010 1:CAS:528:DyaK1MXislejt7c%3D 10213513
18. T Sotobori T Ueda A Myoui, et al. 2006 Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts Exp Cell Res 312 19 3927 3938 1:CAS:528:DC%2BD28XhtFCjsL%2FN 10.1016/j.yexcr.2006.08.024 17022972 (Pubitemid 44633892)
19. N Nitta T Tsuchiya A Yamauchi, et al. 2007 Quantitative analysis of eosinophil chemotaxis tracked using a novel optical device-TAXIScan J Immunol Methods 320 1-2 155 163 1:CAS:528:DC%2BD2sXislKhtLs%3D 10.1016/j.jim.2006.12.010 17289072 (Pubitemid 46349105)
20. K Sano M Yoshikawa S Hayasaka, et al. 2003 Simple non-ion-paired high-performance liquid chromatographic method for simultaneous quantitation of carboxylate and lactone forms of 14 new camptothecin derivatives J Chromatogr B Analyt Technol Biomed Life Sci 795 1 25 34 1:CAS:528:DC%2BD3sXmvVKnsro%3D 10.1016/S1570-0232(03)00485-9 12957166 (Pubitemid 37289422)
21. K Itoh K Yoshioka H Akedo, et al. 1999 An essential part for Rho-associated kinase in the transcellular invasion of tumor cells Nat Med 5 2 221 225 1:CAS:528:DyaK1MXntlOisg%3D%3D 10.1038/5587 9930872 (Pubitemid 29068531)
22. WL Furman KR Crews C Billups, et al. 2006 Cefixime allows greater dose escalation of oral irinotecan: a phase I study in pediatric patients with refractory solid tumors J Clin Oncol 24 4 563 570 1:CAS:528:DC%2BD28XhvFKht7k%3D 10.1200/JCO.2005.03.2847 16446328 (Pubitemid 46630418)
23. IE Kuppens E Dansin H Boot, et al. 2006 Dose-finding phase I clinical and pharmacokinetic study of orally administered irinotecan in patients with advanced solid tumors Clin Cancer Res 12 12 3774 3781 1:CAS:528: DC%2BD28XlvVSltro%3D 10.1158/1078-0432.CCR-05-2368 16778105 (Pubitemid 44000259)
24. RL Drengler JG Kuhn LJ Schaaf, et al. 1999 Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors J Clin Oncol 17 2 685 696 1:CAS:528:DyaK1MXht1Wlsr0%3D 10080615
25. W Wang S Goswami E Sahai, et al. 2005 Tumor cells caught in the act of invading: their strategy for enhanced cell motility Trends Cell Biol 15 3 138 145 1:CAS:528:DC%2BD2MXitVeitrc%3D 10.1016/j.tcb.2005.01.003 15752977 (Pubitemid 40332536)
26. JB Wyckoff SE Pinner S Gschmeissner, et al. 2006 ROCK- and myosin-dependent matrix deformation enables protease-independent tumor-cell invasion in vivo Curr Biol 16 15 1515 1523 1:CAS:528:DC%2BD28XotFWlsLg%3D 10.1016/j.cub.2006.05.065 16890527 (Pubitemid 44142977)
27. U Philippar ET Roussos M Oser, et al. 2008 A Mena invasion isoform potentiates EGF-induced carcinoma cell invasion and metastasis Dev Cell 15 6 813 828 1:CAS:528:DC%2BD1cXhsFWgsbjO 10.1016/j.devcel.2008.09.003 19081071
28. SI Ellenbroek JG Collard 2007 Rho GTPases: functions and association with cancer Clin Exp Metastasis 24 8 657 672 1:CAS:528:DC%2BD1cXhvFGgtrs%3D 10.1007/s10585-007-9119-1 18000759 (Pubitemid 50002983)
29. J Condeelis JE Segall 2003 Intravital imaging of cell movement in tumours Nat Rev Cancer 3 12 921 930 1:CAS:528:DC%2BD3sXpvFahsLc%3D 10.1038/nrc1231 14737122
30. S Giampieri C Manning S Hooper, et al. 2009 Localized and reversible TGFbeta signalling switches breast cancer cells from cohesive to single cell motility Nat Cell Biol 11 11 1287 1296 1:CAS:528:DC%2BD1MXhtlCnu7rN 10.1038/ncb1973 19838175
31. M Vicente-Manzanares JR Cabrero M Rey, et al. 2002 A role for the Rho-p160 Rho coiled-coil kinase axis in the chemokine stromal cell-derived factor-1alpha-induced lymphocyte actomyosin and microtubular organization and chemotaxis J Immunol 168 1 400 410 1:CAS:528:DC%2BD38Xht1Kjuw%3D%3D 11751986
32. FM Vega AJ Ridley 2008 Rho GTPases in cancer cell biology FEBS Lett 582 14 2093 2101 1:CAS:528:DC%2BD1cXms1WgtLk%3D 10.1016/j.febslet.2008.04.039 18460342
33. CD Nobes A Hall 1999 Rho GTPases control polarity, protrusion, and adhesion during cell movement J Cell Biol 144 6 1235 1244 1:CAS:528: DyaK1MXitVKjtbo%3D 10.1083/jcb.144.6.1235 10087266 (Pubitemid 29157301)
34. S Wilkinson HF Paterson CJ Marshall 2005 Cdc42-MRCK and Rho-ROCK signalling cooperate in myosin phosphorylation and cell invasion Nat Cell Biol 7 3 255 261 1:CAS:528:DC%2BD2MXhslSgu7Y%3D 10.1038/ncb1230 15723050 (Pubitemid 40331126)
35. H Yoshikawa K Yoshioka T Nakase, et al. 2009 Stimulation of ectopic bone formation in response to BMP-2 by Rho kinase inhibitor: a pilot study Clin Orthop Relat Res 467 12 3087 3095 10.1007/s11999-009-0976-6 19609629
36. T Kashima K Nakamura J Kawaguchi, et al. 2003 Overexpression of cadherins suppresses pulmonary metastasis of osteosarcoma in vivo Int J Cancer 104 2 147 154 1:CAS:528:DC%2BD3sXhvFyktrY%3D 10.1002/ijc.10931 12569568 (Pubitemid 36249788)
37. Y Pommier C Redon VA Rao, et al. 2003 Repair of and checkpoint response to topoisomerase I-mediated DNA damage Mutat Res 532 1-2 173 203 1:CAS:528:DC%2BD3sXpt1ertbg%3D 14643436
38. Y Pommier J Cherfils 2005 Interfacial inhibition of macromolecular interactions: nature's paradigm for drug discovery Trends Pharmacol Sci 26 3 138 145 1:CAS:528:DC%2BD2MXitVeisb0%3D 10.1016/j.tips.2005.01.008 15749159 (Pubitemid 40313593)
39. J Nitiss JC Wang 1988 DNA topoisomerase-targeting antitumor drugs can be studied in yeast Proc Natl Acad Sci USA 85 20 7501 7505 1:CAS:528: DyaL1cXmt1ajtrg%3D 10.1073/pnas.85.20.7501 2845409